# Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
Canonical URL: https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029
Ticker: AZTA
Company: Azenta Life Sciences
Source: Azenta Life Sciences
Published: 2026-05-05 20:30 EST
Original Source URL: https://investors.azenta.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-08 12:00 EST — [Azenta Completes Sale of B Medical Systems](https://biopharmsignal.com/news/AZTA/azenta-completes-sale-of-b-medical-systems-869ef834) — Source: Azenta Life Sciences
- 2026-05-21 20:05 EST — [Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report](https://biopharmsignal.com/news/AZTA/azenta-publishes-2025-environmental-social-and-governance-esg-report) — Source: Azenta Life Sciences
- 2026-05-05 20:30 EST — [Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029](https://biopharmsignal.com/news/AZTA/azenta-reports-second-quarter-results-for-fiscal-2026-ended-march-31-2026-updates-full-year-fiscal-2026-guidance-and-extends-long-range-plan-to-2029) — Source: Azenta Life Sciences
- 2026-04-29 20:06 EST — [Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-second-quarter-conference-call-and-webcast) — Source: Azenta Life Sciences
- 2026-04-07 12:15 EST — [Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution](https://biopharmsignal.com/news/AZTA/azenta-life-sciences-announces-leadership-transition-to-accelerate-gene-synthesis-strategy-and-multiomics-execution) — Source: Azenta Life Sciences
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)